Common Contracts
5 similar Transaction Agreement contracts by AbbVie Inc., Allergan PLC
TRANSACTION AGREEMENTTransaction Agreement • October 30th, 2022 • Delaware
This TRANSACTION AGREEMENT (this “Agreement”), dated as of June 25, 2019 is by and among AbbVie, a Delaware corporation (“AbbVie”), Venice Subsidiary, LLC, a Delaware limited liability company and a direct wholly owned Subsidiary of AbbVie (“Acquirer Sub”), and Allergan plc, an Irish public limited company with registered number 527629 having its registered office at Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland (“Allergan”).
EX-2.1 2 d771837dex21.htm EX-2.1 EXECUTION VERSION TRANSACTION AGREEMENT dated as of June 25, 2019 among ABBVIE INC. VENICE SUBSIDIARY, LLC and ALLERGAN PLC Page TRANSACTION AGREEMENTTransaction Agreement • May 5th, 2020 • Delaware
This TRANSACTION AGREEMENT (this “Agreement”), dated as of June 25, 2019 is by and among AbbVie, a Delaware corporation (“AbbVie”), Venice Subsidiary, LLC, a Delaware limited liability company and a direct wholly owned Subsidiary of AbbVie (“Acquirer Sub”), and Allergan plc, an Irish public limited company with registered number 527629 having its registered office at Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland (“Allergan”).
EXECUTION VERSION W/3444933 TRANSACTION AGREEMENT dated as of June 25, 2019 among ABBVIE INC. VENICE SUBSIDIARY, LLC and ALLERGAN PLC Page Scheme.......... ..................................................................................Transaction Agreement • May 5th, 2020 • Delaware
This TRANSACTION AGREEMENT (this “Agreement”), dated as of June 25, 2019 is by and among AbbVie, a Delaware corporation (“AbbVie”), Venice Subsidiary, LLC, a Delaware limited liability company and a direct wholly owned Subsidiary of AbbVie (“Acquirer Sub”), and Allergan plc, an Irish public limited company with registered number 527629 having its registered office at Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland (“Allergan”).
TRANSACTION AGREEMENT dated as of June 25, 2019 among ABBVIE INC. VENICE SUBSIDIARY, LLC and ALLERGAN PLCTransaction Agreement • June 25th, 2019 • AbbVie Inc. • Pharmaceutical preparations • Delaware
This TRANSACTION AGREEMENT (this “Agreement”), dated as of June 25, 2019 is by and among AbbVie, a Delaware corporation (“AbbVie”), Venice Subsidiary, LLC, a Delaware limited liability company and a direct wholly owned Subsidiary of AbbVie (“Acquirer Sub”), and Allergan plc, an Irish public limited company with registered number 527629 having its registered office at Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland (“Allergan”).
TRANSACTION AGREEMENT dated as of June 25, 2019 among ABBVIE INC. VENICE SUBSIDIARY, LLC and ALLERGAN PLCTransaction Agreement • June 25th, 2019 • Allergan PLC • Pharmaceutical preparations • Delaware
This TRANSACTION AGREEMENT (this “Agreement”), dated as of June 25, 2019 is by and among AbbVie, a Delaware corporation (“AbbVie”), Venice Subsidiary, LLC, a Delaware limited liability company and a direct wholly owned Subsidiary of AbbVie (“Acquirer Sub”), and Allergan plc, an Irish public limited company with registered number 527629 having its registered office at Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland (“Allergan”).
